News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Release: Health Canada Approves PERJETA™, a New First-In-Class Targeted Therapy for the Treatment of HER2-Positive Metastatic Breast Cancer(1)


4/23/2013 10:42:39 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MISSISSAUGA, ON, April 23, 2013 /CNW/ - While awareness and support for breast cancer research is at an all-time high and Canadians "think pink," one-quarter of Canadian women are still not convinced a breast cancer diagnosis may be fatal.2 Yet, breast cancer can be a very aggressive disease and claims the lives of 100 Canadian women every week.3

Help employers find you! Check out all the jobs and post your resume.

Read at Canada NewsWire


comments powered by Disqus
Health Canada
Roche
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES